Abstract
Beta-blockers are useful in a number of clinical situations. However, the benefits of new short-acting drugs in critically ill patients are not well-known or fully appreciated.
The following article is mainly devoted to the benefits of landiolol with a very short duration of action and extraordinary beta 1 selectivity in patients with tachycardia or tachyarrhythmias and concomitant heart failure to shock, aortic dissection, perioperative period, acute coronary syndromes, takotsubo syndrome, but also angiography.